Taking a hands-on approach to shaping the future of biotech, biopharma, and digital health sectors. Our key contributions include:• Strategic Leadership: Drove executive management and strategy across biotech, biopharma, and digital health, focusing on operations, corporate development, discovery R&D, and financing.• Opportunity Evaluation: Led comprehensive assessments, diving deep into ventures, intellectual property, and licensing to optimize client investment returns.• Global Partnerships: Championed business development, forging solid partnerships with US and Asian biotech firms and facilitating EU product launches, ensuring seamless financing and collaborations.• Fundraising & Business Development: Offered pivotal support in strategic fundraising, corporate, and business development for emerging biopharma ventures.• Expert Advisory: Consulted Cell and Gene Therapy (CGT) and LBP / Microbiome clients, focusing on translational bioengineering, gene modification, and bioprocessing/scale-ups.• Digital Health Leadership: Steered the digital clinical endpoints development, offering guidance and overseeing the clinical trials team. Led the roll-out of pioneering digital clinical endpoints tailored to diverse clients.• Innovative Drug Discovery: Rendered expertise in drug discovery and translational bioengineering, with a particular emphasis on 3D, organoid, and body-on-a-chip models, setting new standards in therapeutic applications.• Entrepreneurship: Founded a digital medicines startup with a mission to combat metabolic inflammatory diseases preemptively. Continuously provided strategic guidance and interim support, ensuring our biopharmaceutical partners stayed ahead of the curve.

Independent Non-Executive Director

COO for a 40+ people biotech startup. In addition to usual C-level duties and close collaboration with Finances, BD, Legal & Compliance, and Scientific functions:* Preparing the company for IPO from operations' perspective* Building and maintaining lab operations (biolab, chemlab)* Rolling out professional IT infrastructure (security, safety, regulatory)* Communications and Marketing (strategy, messaging, channels, events)

As Managing Director, I was responsible for leading business and technology strategy across Zurich, Switzerland, and Cambridge MA, USA while providing digital business solutions for automation, data analysis, data management, storage, deep learning and digital endpoints, leading a team of 3 consultants. Key achievements include: • Provided expert digital health support to develop European COVID-tracing app. • Aided clients engineering industrial-strength, providing robust biomedical data processing and analytics pipelines for deep learning / AI analytical and generative applications.

As Chief Scientific Officer, operating as key Member of Executive team, reporting to CEO, I was responsible for R&D, product management, external innovation, scientific alliances, IP and services. I managed team of 25 people, covering metabolic diseases, inflammation, immuno-oncology, diabetes, and body-on-a-chip devices while operating as C-Suite Executive team member, co-developing company strategy, corporate development, and strategic alliances while attending key investor meetings and contributing to BOD meetings. Key achievements include:• Re-organised department, introducing new products, services, disease areas, business models, people coaching, development processes while leading digital transformation.• Led transformation and refocusing of therapeutic areas and modalities, continually increasing revenue by 30%.• Partnered with CBO / CEO, closing partnerships, including pharma-metabolic, biotech services, industrial screening and pharma immuno-oncology.

Engaged as Consultant, building and leading New Cell Therapy Venture based in Massachusetts, directing strategic planning for cell therapy start-up, covering R&D, product strategy, IP, milestones, partnering and market access. Key achievements include:• Achieved / won $25m investment offer.

As Laboratory Head, reporting to Section Head, Islet Biology, Diabetes Division (Diabetes Lab) and to Global Project Leader, Bioinnovation Unit (Biotherapeutics Lab), responsible for establishing and leading two new laboratories simultaneously. I also led team of 6 associates and scientists, developing stem cell-derived pancreatic microtissues for cell replacement therapy and drug discovery: key achievements include:• Initiated and headed additional new lab with associates and senior scientists, engineering cell lines and biologics using programmable nucleases and recombinases.• Worked on strategic partnership deal with BD for large milestone based alliance with CRO / CDMOs, including project, people, financial planning, milestones and deliverables.

Synthetic Biology in mammalian cells with a focus on cell and gene therapy: Human iPSC reprogramming with genetic circuits for generating liver and pancreatic tissues, oncolytic viruses, and more.